Anti-idiotypic antibody and its use in diagnosis and therapy of Hepatitis C virus related diseases

Details for Australian Patent Application No. 2008202625 (hide)

Owner Rapid Medical Diagnostic Corporation

Inventors Grant, Michael D.

Agent Griffith Hack

Pub. Number AU-A-2008202625

Parent 2002247578

Filing date 13 June 2008

Wipo publication date 3 July 2008

International Classifications

G01N 33/576 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for hepatitis

C07K 16/42 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

3 July 2008 Application Open to Public Inspection

  Published as AU-A-2008202625

3 July 2008 Complete Application Filed

18 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under Reg. 22.2B(2). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008202626-Thioflavin derivatives and their use in diagnosis and therapy of Alzheimer's disease

2008202624-Substantially homogeneous bioaffecting material having a predetermined ratio of bioaffecting component to cell targeting component, the method for making such a material and the method of its use